ALVO
Alvotech
NASDAQ: ALVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.30
-6.25% today
Updated 2026-04-29
Market cap
$1.03B
P/E ratio
33.00
P/S ratio
1.75x
EPS (TTM)
$0.10
Dividend yield
—
52W range
$3 – $12
Volume
0.6M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
6.0
Growth
B5.0
Quality
C+6.0
Profitability
B6.3
Valuation
B3/9
Piotroski F-Score
Weak
-1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$13.83
+319.09%
12-Month target
$2.40
-27.27%
Intrinsic (DCF)
$31.25
Margin of safety
+84.48%
1 Strong Buy3 Buy1 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 10.10% QoQ
+ 84.48% below intrinsic value
+ Debt/equity -7.25x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -1.29 — distress zone
- Thin margins at 4.74%
- Negative free cash flow $-71.47M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $83.03M | $91.43M | $489.68M | $586.32M | $588.90M |
| Net income | $-513.58M | $-551.73M | $-231.86M | $27.92M | $-108.58M |
| EPS | — | — | — | — | $0.10 |
| Free cash flow | $-361.39M | $-358.66M | $-293.84M | $-114.67M | $-71.47M |
| Profit margin | -618.55% | -603.42% | -47.35% | 4.76% | 4.74% |
Peer comparison
Smart narrative
Alvotech trades at $3.30. representing a P/E of 33.00x trailing earnings. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -1.29, it sits in the distress. TTM revenue stands at $588.90M. with profit margins at 4.74%. Our DCF model estimates intrinsic value at $31.25.
Frequently asked questions
What is Alvotech's stock price?
Alvotech (ALVO) trades at $3.30.
Is Alvotech overvalued?
Smart Value Score 37/100 (Grade D, Sell). DCF value $31.25.
What is the price target of Alvotech (ALVO)?
The analyst target price is $13.83, representing +319.1% upside from the current price of $3.30.
What is the intrinsic value of Alvotech (ALVO)?
Based on our DCF model, intrinsic value is $31.25, a +84.5% margin of safety versus $3.30.
What is the future stock price of ALVO by 2030?
Our revenue-driven model estimates Alvotech could reach $4.64 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.
What is Alvotech's revenue?
TTM revenue is $588.90M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-1.29 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.75x
ROE—
Beta0.25
50D MA$3.68
200D MA$6.04
Shares out0.31B
Float0.11B
Short ratio—
Avg volume0.6M
Performance
1 week+11.73%
1 month-4.74%
3 months-29.43%
YTD-29.43%
1 year—
3 years—
5 years—